Categories: Appointment

Syngene Appoints Dr. Mahesh Bhalgat as COO

Bengaluru, July 02, 2019: Syngene International Limited, a leading global Contract Research Organisation, today announced the appointment of Dr. Mahesh Bhalgat as Chief Operating Officer (COO). Dr. Bhalgat will take charge as COO with effect from 1st July, 2019. He comes to Syngene from Shantha Biotechnics, a Sanofi company, where he was responsible for all manufacturing operations, supply chain, engineering projects, HSE, manufacturing excellence and administrative services.

Commenting on the new appointment, Jonathan Hunt, Chief Executive Officer, Syngene International said“We are delighted to have Dr. Bhalgat join the Syngene executive leadership team. Syngene has evolved to be a global scale scientific services provider and Dr. Bhalgat’s significant expertise in R&D, analytical development, technology transfer, regulatory sciences and quality will further enhance Syngene’s position as a global CRO.” 

In a career spanning over 25 years in the field of biotechnology and biologics, Dr. Bhalgat is recognised for his contribution to the commercialization of diagnostic kits, biopharmaceuticals and WHO pre-qualification of vaccines. He has rich experience in diverse areas of biotechnology such as biotherapeutics, vaccines, ag-biotech, and research reagents and has been associated with companies such as Amgen, Monsanto, Celera Genomics, Thermo Fisher, Biological E.

A Ph.D. in Medicinal Chemistry from the University of Utah, he is the Co-Chair of CII’s National Committee of Biotechnology as well as a member of the Biomeriux Scientific Advisory Board, France, United States Pharmacopeia, GCBA committee and the Indian Pharmacopeial Commission.

Corporate Comm India (CCI Newswire)

AddThis Website Tools
The Pharma Times News Bureau

Recent Posts

Arya Vaidya Pharmacy Expands Product Portfolio, Strengthening Its Commitment to Holistic Health and SustainabilityArya Vaidya Pharmacy Expands Product Portfolio, Strengthening Its Commitment to Holistic Health and Sustainability

Arya Vaidya Pharmacy Expands Product Portfolio, Strengthening Its Commitment to Holistic Health and Sustainability

New Delhi, January 10, 2025: Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic healthcare…

2 days ago
The future of healthcare: Five key trends for providers in 2025The future of healthcare: Five key trends for providers in 2025

The future of healthcare: Five key trends for providers in 2025

By Srinath Rao, Senior Vice President, CitiusTech A few decades back, the purpose of watches…

4 days ago
Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack ReportSwitzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

Pharmapack Europe: 'Basel the best location for drug device innovation in Europe thanks to combination…

4 days ago
Quote on HMPV by Doctors of Super Specialty HospitalsQuote on HMPV by Doctors of Super Specialty Hospitals

Quote on HMPV by Doctors of Super Specialty Hospitals

New Delhi, January 07, 2025: HMP virus can travel to the brain, or it can…

5 days ago
Advisory For Hmpv – Key Preventative MeasuresAdvisory For Hmpv – Key Preventative Measures

Advisory For Hmpv – Key Preventative Measures

~ Co-authored by Dr Sanjith Saseedharan, Director-Critical Care, S. L. Raheja Hospital- A Fortis Associate…

5 days ago
40% of Doctor Appointments Dedicated to Family and Friends, Reveals MediBuddy’s 2024 Data40% of Doctor Appointments Dedicated to Family and Friends, Reveals MediBuddy’s 2024 Data

40% of Doctor Appointments Dedicated to Family and Friends, Reveals MediBuddy’s 2024 Data

Patients Embrace Flexibility with 37% of Online Doctor Consultations now happening even After 6 PM,…

6 days ago